Glenmark azelaic acid gel 15% recalled for grainy texture
Glenmark Pharmaceuticals is recalling certain lots of Azelaic Acid Gel, 15%, 50-gram tubes, after customers reported grainy, gritty, or sandy texture. The FDA classifies this as a quality problem with the product's manufacturing process. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Glenmark recalls
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check the tube for NDC 68462-626-52 and a lot number on the list: 19260937A (exp. February 2028), 19261225A or 19261185A (exp. March 2028), or 19261664A or 19261682A (exp. April 2028).
- The notice doesn't say how to get a refund or replacement; contact Glenmark Pharmaceuticals or the pharmacy where you filled it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ 07407, NDC 68462-626-52.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- N/A
- Illnesses reported
- None reported
- Manufactured in
- 619 River Dr, N/A, Elmwood Park, NJ, United States
- Classification
- Class II
- Recall number
- D-0731-2026
In the FDA's words
- Description
- Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ 07407, NDC 68462-626-52. CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received. Lot #: 19260937A, Exp. Date February 2028; 19261225A, 19261185A, Exp. Date March 2028; 19261664A, 19261682A, Exp. Date April 2028. Distribution: Nationwide within the United States. Affected quantity: N/A
- Hazard
- CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
More from Glenmark
See all- Glenmark abiraterone acetate tablets recalled for labeling problem
ModerateFDAOct 23, 2026
- Glenmark Clindamycin Phosphate Foam recalled for damaged, leaking containers
ModerateFDAOct 7, 2026